• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CROSSER CTO RECANALIZATION CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CROSSER CTO RECANALIZATION CATHETERS Back to Search Results
Catalog Number CRES6
Device Problem Overheating of Device (1437)
Patient Problem No Patient Involvement (2645)
Event Date 01/18/2016
Event Type  malfunction  
Manufacturer Narrative
No hospital/medical records or medical images have been made available to the manufacturer the lot number for the device has been provided.A review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that the recanalization catheter allegedly overheated.There was no patient involvement.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted.The lot met all release criteria.Visual/ inspection: the sample was returned used.The core wire was intact.There were no anomalies noted at the tip or along the length of the catheter.Performance/functional evaluation: the device was attached to the transducer of the in-house generator.An in-house injection device was used to flush the catheter with saline.The device was able to produce vibrations throughout the entire length of the catheter.Misting was observed coming out from the distal tip, indicating that the device was vibrating properly.The distal tip of the catheter was pressed against one end of a 5mm plaster tile, and was able to penetrate the tile with no issues.The catheter was activated for a total of 5 minutes and no overheating or melting of the catheter was observed.No anomalies were noted to the catheter during activation.Medical records review: as medical records were not provided, a review could not be performed.Image review: based on the images provided, the posterior tibial artery demonstrated good blood flow can be confirmed.Based on the images provided, the anterior tibial artery blood flow diminished at the level of the talus can be confirmed.Photo review: one electronic photo of the procedure room was reviewed.The photo includes two staff members and the patient lying on a procedural table.The patient is covered in drapes, except for his face.Four monitors showing images are present in the photo.A crosser generator, flowmate injector, and crosser catheter are present.The crosser catheter appears to be connected to the transducer with the crosser generator powered on.An introducer sheath is present and appears to be inserted in the patient.The access site is not visible in the photo, as it is covered by the drapes.A guidewire can be seen inserted through the hub of the introducer sheath.The size of the guidewire could not be determined based on the photo.Based upon the photo provided, the overheating of the crosser catheter could not be confirmed.Conclusion: the investigation is unconfirmed, as the catheter was able to be activated for five minutes during functional testing with no overheating observed.It is unknown if patient (i.E.Length of lesion) and/or procedural issues contributed to this event.It is unknown whether the injector used during the procedure contributed to the catheter reportedly overheating.The definitive root cause could not be determined based upon the available information.Labeling review: the current crosser cto recanalization catheter instructions for use (ifu) provides general instructions for use of the device, as well as warnings, precautions, and potential complications associated with the device.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CROSSER CTO RECANALIZATION CATHETERS
Type of Device
RECANALIZATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key5428723
MDR Text Key38538192
Report Number2020394-2016-00169
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2016
Device Catalogue NumberCRES6
Device Lot NumberGFYA2927
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/05/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received03/28/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/18/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient Weight70
-
-